Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings Inc (MEDP)
:MEDP
Total Valuation
Medpace Holdings has a market cap or net worth of $16.44B. The enterprise value is $14.68B.
Market Cap$16.44B
Enterprise Value$14.68B
Share Statistics
Medpace Holdings has 28,168,222 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,168,222
Owned by Insiders20.49%
Owned by Institutions28.29%
Financial Efficiency
Medpace Holdings’s return on equity (ROE) is 0.49 and return on invested capital (ROIC) is 37.24%.
Return on Equity (ROE)0.49
Return on Assets (ROA)0.19
Return on Invested Capital (ROIC)37.24%
Return on Capital Employed (ROCE)0.45
Revenue Per Employee357.47K
Profits Per Employee68.54K
Employee Count5,900
Asset Turnover1.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medpace Holdings is 40.8. Medpace Holdings’s PEG ratio is 0.61.
PE Ratio40.8
PS Ratio4.88
PB Ratio12.46
Price to Fair Value12.46
Price to FCF17.97
Price to Operating Cash Flow24.05
PEG Ratio0.61
Income Statement
In the last 12 months, Medpace Holdings had revenue of 2.11B and earned 404.39M in profits. Earnings per share was 13.06.
Revenue2.11B
Gross Profit656.30M
Operating Income446.87M
Pretax Income475.92M
Net Income404.39M
EBITDA476.12M
Earnings Per Share (EPS)13.06
Cash Flow
In the last 12 months, operating cash flow was 711.24M and capital expenditures -7.64M, giving a free cash flow of 703.59M billion.
Operating Cash Flow711.24M
Free Cash Flow703.59M
Free Cash Flow per Share24.98
Dividends & Yields
Medpace Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.15
52-Week Price Change66.47%
50-Day Moving Average563.41
200-Day Moving Average408.63
Relative Strength Index (RSI)46.07
Average Volume (3m)301.90K
Important Dates
Medpace Holdings upcoming earnings date is Feb 16, 2026, After Close (Confirmed).
Last Earnings DateOct 22, 2025
Next Earnings DateFeb 16, 2026
Ex-Dividend Date―
Financial Position
Medpace Holdings as a current ratio of 0.93, with Debt / Equity ratio of 49.03%
Current Ratio0.93
Quick Ratio0.93
Debt to Market Cap<0.01
Net Debt to EBITDA-1.09
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Medpace Holdings has paid 71.54M in taxes.
Income Tax71.54M
Effective Tax Rate0.15
Enterprise Valuation
Medpace Holdings EV to EBITDA ratio is 20.51, with an EV/FCF ratio of 17.06.
EV to Sales4.63
EV to EBITDA20.51
EV to Free Cash Flow17.06
EV to Operating Cash Flow16.04
Balance Sheet
Medpace Holdings has $285.35M in cash and marketable securities with $143.97M in debt, giving a net cash position of $141.38M billion.
Cash & Marketable Securities$285.35M
Total Debt$143.97M
Net Cash$141.38M
Net Cash Per Share$5.02
Tangible Book Value Per Share$4.16
Margins
Gross margin is 31.11%, with operating margin of 21.19%, and net profit margin of 19.17%.
Gross Margin31.11%
Operating Margin21.19%
Pretax Margin22.57%
Net Profit Margin19.17%
EBITDA Margin22.58%
EBIT Margin21.19%
Analyst Forecast
The average price target for Medpace Holdings is $531.25, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$531.25
Price Target Upside-7.85% Downside
Analyst ConsensusHold
Analyst Count9
Revenue Growth Forecast13.88%
EPS Growth Forecast23.92%